With the consequences of the global pandemic still reverberating throughout the Asia-Pacific region, governments and businesses in the area continue to focus on the life sciences industry. From startups to global...more
The dynamic life sciences venture capital scene presents investors with a high-risk, high-return proposition. While often faced with a number of challenges, such as limited sources of revenue and capital, to early-stage...more